Vor BiopharmaVOR
13F holders, Q2 2025 (June 30)34holders −11
8new positions
19sold out
1famous investor
$1.61avg. 13F price*
At the end of Q2 2025, 34 institutions reported holding Vor Biopharma Inc. (VOR) in their 13F filings, down 11 from Q1 2025. 8 opened new positions and 19 sold out. The largest holders were Ra Capital Management, L.P. ($64.2M), 5AM Venture Management, LLC ($10.3M) and FMR LLC ($3.4M). One famous investor held it Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Vor Biopharma Inc.
- CUSIP
- 929033108
- Latest filing quarter
- Q3 2025
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $2.2M |
| Exits | 19 | $968K |
All 13F filers, Q1 2025 → Q2 2025: 3,382,213 shares bought and 6,445,568 shares sold, net −3,063,355 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 34 holders
| Ra Capital Management, L.P. | 1.08% | No change | 39,646,039 | $64.2M |
| 5AM Venture Management, LLC | 3.96% | No change | 6,361,723 | $10.3M |
| FMR LLC | 0.00% | Reduce -67.4% | 2,092,686 | $3.4M |
| Vanguard Group Inc. | 0.00% | Reduce -1.3% | 1,915,606 | $3.1M |
| UBS Group AG | 0.00% | Add +18015.2% | 1,531,636 | $2.5M |
| Johnson & Johnson | 0.34% | No change | 1,074,658 | $1.1M |
| Jane Street Group, LLC | 0.00% | Add +169.9% | 525,613 | $851K |
| Sarissa Capital Management LP | 0.53% | No change | 508,016 | $823K |
| HRT Financial LP | 0.00% | New | 474,575 | $768K |
| Renaissance Technologies | 0.00% | Reduce -33.3% | 468,112 | $758K |
| Geode Capital Management, LLC | 0.00% | Reduce -0.6% | 435,560 | $706K |
| Scientech Research LLC | 0.16% | New | 403,859 | $654K |
| BlackRock, Inc. | 0.00% | Reduce -22.6% | 374,763 | $607K |
| Virtu Financial LLC | 0.02% | New | 275,912 | $447K |
| Goldman Sachs Group Inc. | 0.00% | Add +112.8% | 180,788 | $293K |
| Two Sigma Investments, LP | 0.00% | Add +37.9% | 169,636 | $275K |
| State Street Corp. | 0.00% | No change | 115,934 | $188K |
| Two Sigma Securities, LLC | 0.02% | New | 94,394 | $153K |
| Trustees of Columbia University in the City of New York | 0.02% | No change | 91,910 | $149K |
| Citigroup Inc. | 0.00% | New | 87,485 | $142K |
| Northern Trust Corp. | 0.00% | Reduce -50.7% | 72,417 | $117K |
| Bollard Group LLC | 0.00% | No change | 55,555 | $90K |
| XTX Topco Ltd | 0.00% | New | 40,943 | $66K |
| Chicago Partners Investment Group LLC | 0.00% | Reduce -14.5% | 10,887 | $23K |
| JPMorgan Chase & Co. | 0.00% | Add +384.0% | 8,997 | $15K |
| MAI Capital Management | 0.00% | Reduce -98.7% | 3,652 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -33.4% | 2,295 | $4K |
| BNP Paribas Financial Markets | 0.00% | No change | 1,017 | $2K |
| Lanark Financial, Inc. | 0.00% | New | 1,000 | $1K |
| Bank of America Corp. | 0.00% | Add +8.9% | 610 | $989 |
| Morgan Stanley | 0.00% | Reduce -98.6% | 503 | $815 |
| SBI Securities Co., Ltd. | 0.00% | Add +200.8% | 400 | $648 |
| Allworth Financial LP | 0.00% | New | 60 | $98 |
| Royal Bank of Canada | 0.00% | Add +7.3% | 59 | $0 |
"% of holder's portfolio" is VOR's weight in each manager's 13F, not the share of Vor Biopharma Inc. the manager owns.